Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Navelbine in Advanced NSCLC
NCT00005865Phase 2Completed
- Sponsor
- GSK
- Start
- Apr 2000
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of vinorelbine in non-small cell lung cancer (NSCLC), sponsored by GSK. Started Apr 2000; status: completed.
02
Drugs
vinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00005865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005865.